Acetaminophen Toxicity Calculator
Assess acetaminophen toxicity risk from dose ingested and time using the Rumack-Matthew nomogram.
Calculator
Adjust values & calculateFormula
The Rumack-Matthew treatment line plots the serum acetaminophen level at which hepatotoxicity risk begins, starting at 150 mcg/mL at 4 hours post-ingestion and declining with a 4-hour half-life. Dose per kilogram of 150 mg/kg or above is the threshold for potential toxicity. NAC dosing is weight-based at 300 mg/kg total for the 21-hour IV protocol.
Last reviewed: January 2026
Worked Examples
Example 1: Acute Overdose - Above Treatment Line
Example 2: Late Presentation with Hepatotoxicity
Background & Theory
The Acetaminophen Toxicity Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the Acetaminophen Toxicity Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Formula
Treatment Line: Level = 150 x 0.5^((hours - 4) / 4) | Dose Risk: mg/kg = Total Dose / Body Weight
The Rumack-Matthew treatment line plots the serum acetaminophen level at which hepatotoxicity risk begins, starting at 150 mcg/mL at 4 hours post-ingestion and declining with a 4-hour half-life. Dose per kilogram of 150 mg/kg or above is the threshold for potential toxicity. NAC dosing is weight-based at 300 mg/kg total for the 21-hour IV protocol.
Worked Examples
Example 1: Acute Overdose - Above Treatment Line
Problem: A 70 kg adult ingested approximately 15 grams of acetaminophen 4 hours ago. Serum level: 200 mcg/mL. ALT: 30, INR: 1.0.
Solution: Dose per kg = 15,000 mg / 70 kg = 214.3 mg/kg (High Risk > 200)\nRumack-Matthew treatment line at 4 hours = 150 mcg/mL\nSerum level 200 > 150: ABOVE treatment line\nNAC recommended: Yes\nIV Protocol: Loading 150 x 70/1000 = 10.5g, Second 50 x 70/1000 = 3.5g, Third 100 x 70/1000 = 7.0g\nTotal NAC = 300 x 70/1000 = 21.0g over 21 hours\nStage I: GI symptoms expected
Result: Dose: 214 mg/kg (High Risk) | Above treatment line | NAC REQUIRED | Total IV NAC: 21g over 21 hours
Example 2: Late Presentation with Hepatotoxicity
Problem: A 60 kg adult ingested unknown amount approximately 36 hours ago. Serum APAP: 10 mcg/mL. ALT: 5,400, INR: 3.2.
Solution: Time > 24 hours: Nomogram NOT applicable\nALT 5,400 > 1000: Significant hepatotoxicity present\nINR 3.2 > 1.5: Coagulopathy present\nStage III toxicity (72-96h approaching peak injury)\nNAC recommended: Yes, even late presentation reduces mortality\nIV Protocol for 60 kg: Loading 9.0g, Second 3.0g, Third 6.0g\nConsider transplant center referral if meeting Kings College Criteria
Result: Late presentation | ALT 5,400 (hepatotoxicity) | INR 3.2 (coagulopathy) | NAC required | Consider transplant evaluation
Frequently Asked Questions
What is acetaminophen toxicity and how does it cause liver damage?
Acetaminophen, also known as paracetamol, is the most common cause of acute liver failure in the United States and United Kingdom. At therapeutic doses, the liver metabolizes approximately 90 percent of acetaminophen through glucuronidation and sulfation into non-toxic metabolites. However, about 5 to 10 percent is metabolized by cytochrome P450 enzymes, primarily CYP2E1, into a highly reactive intermediate called NAPQI (N-acetyl-p-benzoquinone imine). At normal doses, glutathione rapidly detoxifies NAPQI. In overdose, the glucuronidation and sulfation pathways become saturated, more drug is shunted through the CYP2E1 pathway, and NAPQI production overwhelms glutathione stores. Once glutathione is depleted below approximately 30 percent of normal, NAPQI binds to hepatocellular proteins, causing oxidative damage, mitochondrial dysfunction, and ultimately hepatocyte necrosis.
What dose of acetaminophen is considered potentially toxic?
The generally accepted threshold for potentially toxic acute ingestion in adults is 150 mg/kg or 7.5 grams total, whichever is less. For a 70 kg adult, this equals 10,500 mg or approximately 21 extra-strength tablets of 500 mg each. Doses exceeding 200 mg/kg are associated with high risk of hepatotoxicity, and doses above 300 mg/kg carry a very high risk of severe liver injury. In children under 6 years, the toxic threshold is the same at 150 mg/kg, but children generally have better outcomes than adults due to higher glutathione regeneration capacity. Patients with chronic alcohol use, malnutrition, or concurrent use of CYP2E1-inducing drugs may develop toxicity at lower doses because their glutathione stores are already depleted and CYP2E1 activity is enhanced, producing more NAPQI from smaller doses.
What are the four stages of acetaminophen toxicity?
Acetaminophen toxicity progresses through four distinct clinical stages. Stage I spans 0 to 24 hours after ingestion and is characterized by nausea, vomiting, diaphoresis, and malaise, though many patients appear deceptively well. Laboratory values are typically normal during this phase. Stage II occurs from 24 to 72 hours and is marked by the onset of hepatotoxicity with rising aminotransferase levels, right upper quadrant pain, and possibly elevated bilirubin. Patients may feel temporarily better as GI symptoms resolve. Stage III spans 72 to 96 hours and represents peak hepatotoxicity with AST and ALT levels potentially exceeding 10,000 IU/L, coagulopathy with rising INR, metabolic acidosis, renal failure, and encephalopathy. Fulminant hepatic failure and death can occur during this stage. Stage IV begins after 96 hours in survivors and represents recovery, with normalization of liver function tests over days to weeks.
When should activated charcoal be given for acetaminophen overdose?
Activated charcoal can be beneficial if administered within 1 to 2 hours of acetaminophen ingestion, and some evidence supports a benefit up to 4 hours post-ingestion. The standard dose is 1 gram per kilogram of body weight, typically 50 to 100 grams in adults. Activated charcoal adsorbs acetaminophen in the gastrointestinal tract, reducing absorption by approximately 50 to 90 percent when given within 1 hour and 40 to 50 percent at 2 hours. It should not be given if the patient has a reduced level of consciousness without airway protection due to aspiration risk. Charcoal does not interfere with IV NAC administration but may reduce absorption of oral NAC if given concurrently. If oral NAC is planned, it should be administered at least 1 to 2 hours after charcoal. In cases where the patient presents more than 4 hours after ingestion, activated charcoal is generally not beneficial and treatment focuses on NAC administration.
How does chronic acetaminophen use differ from acute overdose in toxicity assessment?
Chronic or repeated supratherapeutic ingestion presents unique challenges that differ significantly from acute overdose assessment. The Rumack-Matthew nomogram cannot be used because there is no single defined ingestion time point. Instead, clinicians rely on serum acetaminophen levels, liver function tests, and clinical presentation. A detectable serum acetaminophen level combined with elevated aminotransferases in the setting of chronic use suggests ongoing hepatotoxicity. Risk factors that increase susceptibility to chronic toxicity include chronic alcohol consumption, fasting or malnutrition, concurrent use of CYP2E1-inducing medications, and pre-existing liver disease. The threshold for chronic toxicity may be as low as 4 grams per day in high-risk patients, which is the maximum recommended therapeutic dose. Treatment with NAC should be initiated if there is any evidence of liver injury with a history of repeated excessive acetaminophen use.
What laboratory tests should be ordered when evaluating acetaminophen toxicity?
The initial laboratory workup for suspected acetaminophen toxicity should include a serum acetaminophen level drawn at 4 hours post-ingestion or immediately if the patient presents after 4 hours. Hepatic function tests including AST, ALT, bilirubin, and alkaline phosphatase establish baseline liver function and detect early injury. A complete metabolic panel assesses renal function with creatinine and BUN, electrolytes, and blood glucose. Coagulation studies including INR and PT evaluate synthetic liver function and predict severity. Arterial blood gas with lactate helps identify metabolic acidosis, which is an ominous prognostic sign. Serial acetaminophen levels can assess the elimination half-life, where a half-life exceeding 4 hours suggests hepatic dysfunction. Lipase and amylase may be checked if pancreatitis is suspected. In cases where coingestants are possible, a toxicology screen, salicylate level, and ethanol level should be obtained.
References
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy